Impact of ranolazine on ventricular arrhythmias – A systematic review

Ranolazine is a new medication for the treatment of refractory angina. However, except its anti‐anginal properties, it has been found to act as an anti‐arrhythmic. The aim of our systematic review is to present the existing data about the impact of ranolazine in ventricular arrhythmias. We searched...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Arrhythm
Hauptverfasser: Bazoukis, George, Tse, Gary, Letsas, Konstantinos P., Thomopoulos, Costas, Naka, Katerina K., Korantzopoulos, Panagiotis, Bazoukis, Xenophon, Michelongona, Paschalia, Papadatos, Stamatis S., Vlachos, Konstantinos, Liu, Tong, Efremidis, Michael, Baranchuk, Adrian, Stavrakis, Stavros, Tsioufis, Costas
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2018
Schlagworte:
Clinical Reviews
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5891418/
https://ncbi.nlm.nih.gov/pubmed/29657587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/joa3.12031
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge